Current Approaches in the Multimodal Management of Asthma in Adolescents-From Pharmacology to Personalized Therapy
- PMID: 37760870
- PMCID: PMC10525469
- DOI: 10.3390/biomedicines11092429
Current Approaches in the Multimodal Management of Asthma in Adolescents-From Pharmacology to Personalized Therapy
Abstract
Asthma and adolescence are two sensitive points and are difficult to manage when they coexist. The first is a chronic respiratory condition, with frequent onset in early childhood (between 3 and 5 years), which can improve or worsen with age. Adolescence is the period between childhood and adulthood (12-19 years), marked by various internal and external conflicts and a limited capacity to understand and accept any aspect that is delimited by the pattern of the social circle (of the entourage) frequented by the individual. Therefore, the clinician is faced with multiple attempts regarding the management of asthma encountered during the adolescent period, starting from the individualization of the therapy to the control of compliance (which depends equally on the adverse reactions, quality of life offered and support of the close circle) and the social integration of the subject, communication probably having a more important role in the monitoring and evolution of the condition than the preference for a certain therapeutic scheme. Current statistics draw attention to the increase in morbidity and mortality among children with bronchial asthma, an aspect demonstrated by the numerous hospitalizations recorded, due either to an escalation in the severity of this pathology or to faulty management. The purpose of this article is to review the delicate aspects in terms of controlling symptoms and maintaining a high quality of life among teenagers.
Keywords: asthma; eosinophils; interleukin; multimodal therapy; teenager.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S49-S67. doi: 10.1093/jcag/gwy056. Epub 2018 Nov 2. J Can Assoc Gastroenterol. 2019. PMID: 31294385 Free PMC article.
-
Asthma in adolescence: Is there any news?Pediatr Pulmonol. 2017 Jan;52(1):129-138. doi: 10.1002/ppul.23498. Epub 2016 Jun 6. Pediatr Pulmonol. 2017. PMID: 27273858 Review.
-
Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.Pediatrics. 2001 Sep;108(3):E48. doi: 10.1542/peds.108.3.e48. Pediatrics. 2001. PMID: 11533366 Clinical Trial.
-
Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007.J Allergy Clin Immunol. 2007 Nov;120(5 Suppl):S94-138. doi: 10.1016/j.jaci.2007.09.043. J Allergy Clin Immunol. 2007. PMID: 17983880
-
Upper and lower airway pathology in young children with allergic- and non-allergic rhinitis.Dan Med Bull. 2011 May;58(5):B4278. Dan Med Bull. 2011. PMID: 21535990 Review.
Cited by
-
Multicomponent intervention for schoolchildren with asthma: Pilot cluster randomized controlled trial.J Allergy Clin Immunol Glob. 2025 Jan 18;4(2):100418. doi: 10.1016/j.jacig.2025.100418. eCollection 2025 May. J Allergy Clin Immunol Glob. 2025. PMID: 40008092 Free PMC article.
References
-
- National Center for Environmental Health Most Recent National Asthma Data. [(accessed on 30 June 2023)];2022 Available online: https://www.cdc.gov/asthma/most_recent_national_asthma_data.htm.
-
- Vilar de Assis E., Santana M.D.R., Feitosa A.N.A., Alves de Sousa M.N., Isidório U.A., Valenti V.E., Fonseca F.L.A. Prevalence of Asthma symptoms and risk factors in adolescents. Journal of Human Growth and Development. J. Hum. Growth Dev. 2019;29:110–116. doi: 10.7322/jhgd.157758. - DOI
Publication types
LinkOut - more resources
Full Text Sources